About This Video
Canadian Securities Exchange (CSE)’s Anil Mall recently caught up with Trent Woloveck, Chief Strategy Director at Jushi Holdings Inc. (CSE:JUSH) to discuss the potential impact of cannabis rescheduling in the US and how the company could benefit from positive legislative changes in 2024. Trent also provides a recap of the company's wins in 2023 and shares insights about the prospects for Jushi's multi-state portfolio of assets including those benefitting from the transition to adult-use markets.
Read the TranscriptAuto-generated by YouTube; names and terms may be misspelled.
thanks for tuning into another CSC listed issuer update today we have Trent wbec Trent is the chief strategy director of juy Holdings Inc it's j us on the csse I'm ail Maul representing the Canadian Securities Exchange Trent thank you so much for your time today I hope you're doing well good morning andelle thanks for having me on this morning absolutely frent you know a lot of our viewers are
familiar with Jui for but for some of them that might not be too familiar with what Jui does why don't you give us a brief introduction to Jui and then we'll get into our conversation sure so Jui is a multi-state operator we've been publicly listed since June of 2019 we operate in seven states five of which were vertical meaning we cultivate manufacture and Retail with really
two growth high growth markets in Pennsylvania and Virginia and looking forward to continuing to to grow the business moving forward you know tread cannabis it's a it's still a very maturing industry still lots of growth to happen currently the big topic it's it's been potentially rescheduling why don't why don't you paint a picture for not only myself but our audience of what this could mean for
Jui and the industry as a whole sure I think you know first and foremost it continues to normalize in societal views you know what cannabis Is So currently with cannabis being a schedule one narcotic that means it's highly addictive and no medical benefits with the FDA CL HHS recommendation going to schedule 3 I think that validates a lot of the work the industry's been doing you know for a
long long time myself being in the industry since 2009 it it it really does validate you know a lot of the patient and consumer wins that that have been going on for quite some time and so with that reclassification of of can AB you know being requested by President Biden back in October of 2022 and the HHS coming out with their
recommendation you know on August 30th of 2023 we're now kind of in the process of waiting for the the DEA to come back and and make sure hey they have some rules and regs in place and and be you know not not having the US foot fault from a legal perspective and so what does 28 do for do for the industry I think you know what we
know it absolutely does is remove us from the taxation of 280e so I know you know from an investor standpoint that opens you know a lot of free cash flow for these businesses you know Jui being a little bit heavier and focused from a retail perspective it definitely outweighs for us versus somebody that may focus a little bit more on
wholesale and so we're really excited about you know not only the free cash flow that would be generated for the business but again just the the normalization of of cannabis within the United States well said and I I really appreciate that Insight you know and so as the industry matures where where do you see the next series of wins in the business and and what might be some
of the challenges that are still there obviously banking is one of the big ones but are there any others that you want to talk about yeah sure I I I think you know it's important to understand you know with with normalization with the rescheduling of cannabis you'll see that safer banking kind of veil pass it it shortly on the heels of that rescheduling in my opinion and so you
know being able to have access to to financial institutions you know financial markets I think just continues to help you know build on the strong fundamentals that you know juy has along with a lot of the other us Multistate operators and so you know I think that's first and foremost you know being able to to have that acceptance have that ability to you
know leverage Capital Growth for an industry that quite frankly is a growth industry and so getting away from worrying about free cash flow worrying about public markets that that is going to be a a huge lift for the industry as a whole but then you're going to continue to see you know States normalize and move towards adult use cannabis you know back in November Ohio passed a ballot
initiative you know 60 plus or or or excuse me 50 plus per high 50s in a very conservative State and so you know we have a vertically integrated business there cultivation and Manufacturing one store we'll look to grow there from a retail perspective and look make investments into the State hire people pay more taxes and so I think you're just going to continue to
see those dominoes fall we have a bill for adult use on the governor's desk in Virginia that's passed the legis legislature so we're excited about that growth where we have you know 95,000 Square ft of cultivation manufacturing and six retail operational stores in Northern Virginia and look in Pennsylvania the governor's come out in his State of the Union budget address he expects real tax dollars to flow
into the state to the tune of $250 million and you know there's a bill out there that's bipartisan in the Senate and so now that they're coming back into session I think you know we'll really start to see some movement there and then obviously you know ju's not in Florida but it's pretty important you know bellweather state for us and I think they'll have a ballot initiative
you know on the docket come November of this year so a lot of exciting things not only happening at the federal level but more importantly for these businesses at the at the state level as well while we're on this growth topic you want to maybe walk us through ju's portfolio of assets and and your current growth sure so you know we continue to see the maturity of Virginia
with the medical market and so you know we've seen quarter over quarter you know high high single digits low double digits growth and I think we continue to see that that's that's something that's you know going to continue Pennsylvania has kind of plateaued just because they have such strong pent patient adoption already five five and a half percent of the total population and so we'll
continue to see you know pricing stabilized there but obviously with adult use and how quick we could get that implemented there you're you're going to see a great lift there towards the back end of the year Massachusetts where we have two stores I think we have you know a top three store in the state that's been a great market for us Ohio obviously gearing up
to flip to adult use at the beginning of September Illinois we've seen you know strong stabilization of our two s stores which sit on the border of Missouri which transitioned you know to adult use at the beginning of 2023 we've seen people start to come back over because of you know pricing selection and quality of product and our Bloomington normal store have fortunately not really been impacted by
by any new licenses and then you have Nevada which is you know starting to stabilize it's been a tough Market just because of all the free money that was you know sosing around the economy all went to Vegas all went to Nevada and so we feel feel good about where we're at there and then you know we have one operational store left in
California and so yeah that'll be what it will be good news is it's not a drag from a cash flow perspective so that's kind of our our high level portfolio of of where we're at well said now the company did put out 2023 Financial results you want to maybe walk us through some of the highlights and and maybe a recap for 2023 sure so you know from a revenue
perspective we were right around $270 million you know low 40s eida that's a huge win for us we saw you know continued growth of of iida as a percent of Revenue throughout the entire year back in 2022 we weren't really even in iida producing business so you know our focus on profitability managing sgna Opex and so on and so forth you
know was a huge win for us being able to really dial in you know our retail flow and Staffing was was a huge Plus for us and so you saw that that profitability you know Skyrocket quite frankly we are also able to to dial in our grower processor facilities both in in in PA and VA and Massachusetts which allowed us to push more of our own branded products
through through our stores we got to about 55% of our Shelf space from an overall company perspective where we are vertically integrated of of selling through our own products that really does increase the the margins of the business and then we are also able to grow our wholesale business in 2023 you know 30% up year-over-year where majority of companies were were staying flat if not down and so you know
bringing 175 new SKS to Market in Q4 is only going to continue for us into 2024 and Beyond and so we feel really good about you know where we're going both from a margin perspective but but from a a fundamental business perspective as well any other milestones for 2024 that you are able to talk about yeah look I I think you know us being able to to open up the
last couple dispensaries we're we're able to do really dial in and drive you know product growth new product growth out of our our Stores knowing what the demand is from you know both our patients but also our customers is is something that's that's on the Forefront and then look I think for us it's it's cleaning up our balance sheet taking care of that maturity at
the end of the year and then hopefully with Federal normalization and or a couple of our states transitioning from from medical to adult youths we can go back into you know m&a mode you know being able to beef up our our retail footprint and you know existing markets Andor new markets are are really something that we've built this business on and want to
continue to build build this business on you know you you you mentioned something that I'm quite curious about because over the years you know sui has had a strong footprint what have you and your team learned about consumer behavior and your products based of the data that you your team has collected over the years were there any surprises yeah I think you know the the maturity of of cannabis industry as
a whole over the last let's call it two two and a half three years you used to be able to just grow cannabis and put it in a bag and you sold cannabis that's not really the case anymore and so what we've seen and and and and really observed through our retail channels is a what's inside the bag really matters the quality and the
standardization of the product whether that's you know a flower a vape pen a concentrate a gummy a chocolate you you need to have have high quality product in that bag for it to sell we've pushed really hard our GPS to do that and they've answered which is a great feeling luckily and so not only that but you're starting to see you know costs come down as you scale
facilities and so pricing compression which has been a very real thing in the industry over the last couple years that that costing is going to start coming down along with it so you can maintain profitability that's that's a super important thing but also from a product's perspective you know most people are interested in buying you know a half ounce or an ounce now or a one gr
card or a two G card even now versus like a half gram or an eighth you know over the last you know five plus years and so you know you're starting to see that incremental package become bigger and so that way you know in with inflation and other things being stretched from a pocket pocket perspective people are still wanting their cannabis which is a huge positive
which a win for all of us now you mentioned earlier you've been in the industry since 2009 if I'm not wrong can you maybe talk touch on a little bit of your background how you got into this space sure so I was fortunate enough to graduate with a finance degree right in 2008 so beautiful time to to have that happen so you know those
who can't Bank go into Consulting and so did that for a couple years however my cousin who moved out to Denver Colorado you know they had some some changes from a a regulatory standpoint that you know didn't allow people to own equity that weren't two-year residents and so I was able to make my first investment through my cousin at that time as she was rolling
up businesses and then I moved out to Denver with Cardinal Health a big pharmaceutical medical supply distributor in in in 2012 and saw the ballot initiative pass that November ended up inventing a child resistant exit bag meaning a package that people needed to have so kids couldn't get in it when they sold adult youths here in Colorado starting January 1st of 2014 worked
in my cousin's retail store for for a couple months and then started their own business and you know did some Consulting work help people win licenses across the country joined a large vertically integrated company here in Colorado called The Green Solution as we were kind of growing and expanding outside of of the state of Colorado we needed some capital and fortunately I got to meet our CEO
chairman a co-founder Jim Copo through Dennis ARS another co-founder of Jui former CEO chairman of organogram and we've been having fun and running the business growing the business ever since the the you know late 2017 early early 2018 so it's been a wild ride and it's it's not stopping anytime soon and so looking forward to to continuing to progress the industry with this Federal
normalization that's coming and speaking of fun Trent I really enjoyed this conversation I I feel like we could probably talk about this for a long time and go through a lot of stuff which which I'm I'm eager to do but I I know I know part of this clip is making sure that our audience knows about the company and what your focus is we always encourage our viewers to go to your
website sign up for your press releases newsletter do their due diligence and of course reach out to you and your team should they have questions where would you like to direct our viewers yeah I think irco.com from an email perspective it's all on our website juy co.com you'll find a lot of fun exciting things there we're very Tech forward company and so go there and and we'll be in
touch with you you know TR why don't we do this again maybe towards the end of summer where we can provide another update to our our issuers I'm going to give you the last 30 seconds for any messaging you want to provide to our audience on why they should be paying attention to Jui as a company and you and your team as leaders in this space yeah absolutely and I appreciate again
the time today and and the focus on Jui you know for us at Jui we're in unique position with a lot of optionality and a lot of growth you know over 60 65% of our stores are still in a medical market and so as we transition to adult use you'll see a lot of torque left within the business and leverage
for growth not only at a a revenue perspective but from an iida perspective which makes us a highly coveted business both from an m a merger perspective but also from an acquisition perspective and so looking forward to being able to to capitalize and and and Garner shareholder value from that perspective thank you so to our viewers watching you've been listening
to Mr Trent vulc he's the chief strategy director of Jui Holdings it's Jus and Trent again I really appreciate you taking the time to talk to me today and we look forward to hosting you on again our team at the CSC wishes you and your team at Jui nothing but success as you move forward in this path I appreciate it have a great
day



